Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 144 Links/Repositories
ID/Name Source Type
[AlzPED] (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
28520620 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression
25882496 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] (−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice
24356899 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A comprehensive multiomics approach toward understanding the relationship between aging and dementia
26564964 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A curcumin/melatonin hybrid, 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide, ameliorates AD-like pathology in the APP/PS1 mouse model
25893520 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
17904756 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
27550730 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease
27129593 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
28709449 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
21992552 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository